Angelika Eggert

21PUBLICATIONS
234CO-AUTHORS
Medical infection agents (incl. prions)Molecular targetsHaematological tumoursPredictive and prognostic markersCellular nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Oct 01, 2026
Quantitative and sensitive neuroblastoma minimal residual disease detection using extrachromosomal DNA (ecDNA) breakpoints.

|Jul 10, 2026
The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric Cancers.

|Aug 07, 2025
Extrachromosomal DNA-Driven Oncogene Dosage Heterogeneity Promotes Rapid Adaptation to Therapy in MYCN-Amplified Cancers.

Giulia Montuori, Fengyu Tu, Di Qin

|Jan 06, 2025
Serially Quantifying TERT Rearrangement Breakpoints in ctDNA Enables Minimal Residual Disease Monitoring in Patients with Neuroblastoma.

Jan F Hollander, Annabell Szymansky, Jasmin Wünschel

|Oct 26, 2024
Targeting KDM1A in Neuroblastoma with NCL-1 Induces a Less Aggressive Phenotype and Suppresses Angiogenesis.

Annika Sprüssel, Takayoshi Suzuki, Naoki Miyata

|Oct 16, 2024
Management of Busulfan-Induced Lung Injury in Pediatric Patients with High-Risk Neuroblastoma.

Sveva Castelli, Anne Thorwarth, Claudia van Schewick

Pageof 4

Frequent Collaborators

14 joint publications

Johannes H Schulte

12 joint publications

Hedwig E Deubzer

10 joint publications

Anton G Henssen

7 joint publications

Annabell Szymansky